Association Between ECG Findings and Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score: A Cross-Sectional Analysis of a Cohort Study
- PMID: 40642562
- PMCID: PMC12241447
- DOI: 10.1002/hsr2.71026
Association Between ECG Findings and Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score: A Cross-Sectional Analysis of a Cohort Study
Abstract
Background and aims: Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, making early detection and risk assessment critical. Various clinical tools, including the Atherosclerotic Cardiovascular Disease (ASCVD) risk score, have been developed to predict cardiovascular risk. This study aimed to evaluate the association of various Electrocardiogram (ECG) findings with 10-year ASCVD risk scores in asymptomatic individuals without prior cardiovascular events, using data from the Shiraz Heart Study (SHS).
Materials and methods: This cross-sectional study included participants aged 40-70 years from the Shiraz Heart Study (SHS). Inclusion criteria required complete ECG data and recorded ASCVD risk factors. ECG findings, encompassing both continuous and categorical variables, were reviewed by trained cardiologists. ASCVD risk scores were calculated using demographic and clinical variables. Statistical analyses, including multivariate regression, assessed associations between ECG parameters and 10-year ASCVD risk scores, adjusting for key confounders.
Result: A total of 1471 participants were included in the study, with 44.5% male (N = 654) and a mean age of 51.65 years (SD = 7.84). The mean ASCVD score was 5.49 (SD = 6.41). Significant associations were found between continuous ECG variables, such as P-wave duration, PR interval, QRS duration, and QRS axis, with ASCVD risk. Categorical ECG findings, including ST depression, ST elevation, left bundle branch block (LBBB), prolonged P-wave duration, and left atrial enlargement, were also significantly associated with ASCVD scores. Multivariate linear regression identified ST depression (B = 0.060, p < 0.001) and LBBB (B = 0.031, p = 0.039) as independent predictors of ASCVD risk, after adjusting for confounders such as age, gender, hypertension, diabetes, and cholesterol levels.
Conclusion: ST depression and LBBB show a modest association with cardiovascular risk stratification using the 10-year ASCVD risk score. Incorporating these ECG markers into clinical assessments may aid in identifying high-risk individuals, enabling more personalized interventions and refining cardiovascular risk prediction models.
Keywords: ST‐segment depression; aatherosclerotic cardiovascular disease; bundle‐branch block; cardiovascular risk prediction; electrocardiography.
© 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3. Cochrane Database Syst Rev. 2017. PMID: 28263370 Free PMC article.
-
Evaluation of the ultrasonic arterial measurement and analysis system for predicting 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.Quant Imaging Med Surg. 2025 Jun 6;15(6):4921-4934. doi: 10.21037/qims-24-1620. Epub 2025 Jun 3. Quant Imaging Med Surg. 2025. PMID: 40606398 Free PMC article.
-
Is Kinesiophobia Associated With Quality of Life, Level of Physical Activity, and Function in Older Adults With Knee Osteoarthritis?Clin Orthop Relat Res. 2025 Apr 1;483(4):667-676. doi: 10.1097/CORR.0000000000003278. Epub 2024 Oct 9. Clin Orthop Relat Res. 2025. PMID: 39387500
-
Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.Prog Cardiovasc Dis. 2023 May-Jun;78:67-73. doi: 10.1016/j.pcad.2023.03.002. Epub 2023 Mar 15. Prog Cardiovasc Dis. 2023. PMID: 36931545
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
References
-
- Mensah G. A., Roth G. A., and Fuster V., “The Global Burden of Cardiovascular Diseases and Risk Factors,” Journal of the American College of Cardiology 74, no. 20 (2019): 2529–2532. - PubMed
-
- Vaduganathan M., Mensah G. A., Turco J. V., Fuster V., and Roth G. A., “The Global Burden of Cardiovascular Diseases and Risk,” Journal of the American College of Cardiology 80, no. 25 (2022): 2361–2371. - PubMed
-
- Beswick A. D., Brindle P., Fahey T., and Ebrahim S., National Institute for Health and Clinical Excellence: Guidance. A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) (Royal College of General Practitioners (UK), 2008). - PubMed
-
- Kannel W. B., Dawber T. R., Kagan A., Revotskie N., and Stokes J., “Factors of Risk in the Development of Coronary Heart Disease—Six‐Year Follow‐up Experience: The Framingham Study,” Annals of Internal Medicine 55 (1961): 33–50. - PubMed
-
- Conroy R., “Estimation of Ten‐Year Risk of Fatal Cardiovascular Disease in Europe: The SCORE Project,” European Heart Journal 24, no. 11 (2003): 987–1003. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials